NxStage(R) to Recognize Several Key Milestones at American Society of Nephrology's Renal... ( Number of active users of NxStage H...)

NxStage(R) to Recognize Several Key Milestones at American Society of Nephrology's Renal Week 2007

Date:10/31/2007

Number of active users of NxStage Home Hemodialysis System exceeds 2007

patients in 2007, having increased 290 percent in past 18 months Seven of the Top Ten Hospitals for Kidney Disease are now NxStage Partners

NxStage closes acquisition of Medisystems and announces launch of

innovative Streamline(TM) Airless Blood Tubing System

LAWRENCE, Mass., Oct. 31 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), will recognize at the American Society of Nephrology's Renal Week 2007 (October 31 through November 5, 2007 in San Francisco, CA), several key milestones supporting its mission to transform renal therapy with innovative yet simple solutions that benefit patients, caregivers and society.

NxStage, the leading manufacturer of dialysis machines indicated for home use and the first truly portable home hemodialysis machine, announced that this month it has reached a new patient adoption milestone of 2007 patients in the year 2007 using the NxStage(R) System One(TM). This more than doubles the number of patients attained during Q4 2006 and represents 290 percent growth over the past 18 months. NxStage reached 2007 patients in early October of this year, and 1957 as of September 30, 2007. More frequent home hemodialysis with the NxStage System One has been shown to offer patients both health and quality of life benefits. The System One is now available at over 300 dialysis centers in markets throughout the United States.

Additionally, NxStage announced that seven of the top ten hospitals, as reported by U.S. News and World Report's ranking of hospitals for kidney disease, are now NxStage partners for their intensive care therapies. "Our system has proven its value com
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin Cells Have the Ability to Recognize, Transport and Utilize L-ergothioneine (EGT) As A Protector Against Oxidative Damage
2. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
3. Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
4. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:

NxStage(R) to Recognize Several Key Milestones at American Society of Nephrology's Renal...( Number of active users of NxStage H...),Health